S.A. Mason’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $167K | Sell |
3,611
-498
| -12% | -$23.1K | 0.08% | 185 |
|
|
2025
Q1 | $251K | Buy |
4,109
+181
| +5% | +$11K | 0.13% | 148 |
|
|
2024
Q4 | $222K | Sell |
3,928
-158
| -4% | -$8.94K | 0.12% | 161 |
|
|
2024
Q3 | $211K | Buy |
4,086
+2
| +0% | +$103 | 0.11% | 163 |
|
|
2024
Q2 | $170K | Buy |
4,084
+2
| +0% | +$83 | 0.1% | 172 |
|
|
2024
Q1 | $221K | Buy |
4,082
+152
| +4% | +$8.24K | 0.13% | 147 |
|
|
2023
Q4 | $202K | Sell |
3,930
-999
| -20% | -$51.3K | 0.14% | 151 |
|
|
2023
Q3 | $286K | Sell |
4,929
-331
| -6% | -$19.2K | 0.21% | 120 |
|
|
2023
Q2 | $365K | Hold |
5,260
| – | – | 0.26% | 103 |
|
|
2023
Q1 | $365K | Sell |
5,260
-129
| -2% | -$8.94K | 0.26% | 103 |
|
|
2022
Q4 | $388K | Sell |
5,389
-185
| -3% | -$13.3K | 0.29% | 95 |
|
|
2022
Q3 | $396K | Buy |
5,574
+1
| +0% | +$71 | 0.31% | 89 |
|
|
2022
Q2 | $429K | Buy |
5,573
+50
| +0.9% | +$3.85K | 0.31% | 92 |
|
|
2022
Q1 | $403K | Buy |
5,523
+501
| +10% | +$36.6K | 0.25% | 103 |
|
|
2021
Q4 | $313K | Buy |
5,022
+1
| +0% | +$62 | 0.19% | 125 |
|
|
2021
Q3 | $297K | Buy |
5,021
+1
| +0% | +$59 | 0.2% | 129 |
|
|
2021
Q2 | $335K | Buy |
5,020
+1
| +0% | +$67 | 0.23% | 119 |
|
|
2021
Q1 | $317K | Buy |
5,019
+301
| +6% | +$19K | 0.24% | 114 |
|
|
2020
Q4 | $293K | Buy |
4,718
+1
| +0% | +$62 | 0.24% | 110 |
|
|
2020
Q3 | $284K | Sell |
4,717
-7
| -0.1% | -$421 | 0.27% | 99 |
|
|
2020
Q2 | $278K | Buy |
4,724
+1
| +0% | +$59 | 0.29% | 95 |
|
|
2020
Q1 | $263K | Buy |
4,723
+109
| +2% | +$6.07K | 0.32% | 92 |
|
|
2019
Q4 | $296K | Buy |
+4,614
| New | +$296K | 0.28% | 101 |
|